ASCEND BY NTHRYS
Research Abroad Products

Genomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 157–168 of 2250 project topics
Medication Therapy Management Software with Genomic Insights
A mobile and web platform enabling pharmacists to conduct comprehensive medication reviews enriched with patient pharmacogenomic data to identify drug interactions and optimization opportunities. Unlocks revenue through integration with MTM billing codes, pharmacy management systems, and partnerships with employers and health plans seeking cost reduction.
Pharmacogenomics Implementation Service Platforms Click to view more details →
Ultra-Deep Variant Calling for Minimal Residual Disease Monitoring
Advanced genotyping platforms detect ultra-low-frequency variants and somatic mutations from high-depth sequencing data for minimal residual disease, circulating tumor DNA, and treatment response monitoring applications. These specialized tools unlock new revenue streams for liquid biopsy companies, oncology centers, and personalized medicine providers through sensitive disease surveillance capabilities.
Variant Discovery and Genotyping Click to view more details →
Pangenome-Based Variant Discovery and Comparative Genotyping Services
Next-generation genotyping services leverage pangenome references and graph-based approaches to discover and accurately genotype variants missed by traditional linear reference methods, including structural and complex variants. These offerings enable agricultural genomics, population genetics, and precision medicine companies to capture previously undetected genetic diversity and gain competitive advantages in variant discovery.
Variant Discovery and Genotyping Click to view more details →
Pharmacogenomics Data Standardization and Interoperability Platform
An infrastructure-as-a-service platform that standardizes pharmacogenomic test results into HL7/FHIR-compliant formats for seamless exchange between labs, pharmacies, EHRs, and payers. Creates network effects and sticky revenue through integration fees, data licensing to research institutions, and enabling telehealth pharmacogenomics services across disparate systems.
Pharmacogenomics Implementation Service Platforms Click to view more details →
AI-Powered Tumor Mutation Profiling SaaS Platform
A cloud-based software platform that automatically analyzes whole genome sequencing data to identify somatic mutations, copy number variations, and structural variants in tumor samples with clinical-grade accuracy. Enables oncology labs and hospitals to deliver comprehensive genomic reports in 48 hours, commanding premium pricing of $3,000-$8,000 per patient test and capturing market share from traditional sequencing providers.
Precision Oncology Genomics Platform Development Click to view more details →
Somatic Mutation Calling in Tumor-Normal Pairs
Applying Mutect2, Strelka2, and VarScan2 for calling somatic SNVs, indels, and CNVs in matched tumor-normal whole genome or exome sequencing.
Cancer Genomics Click to view more details →
Real-Time Liquid Biopsy ctDNA Detection and Monitoring Tool
A proprietary software-hardware integration that processes circulating tumor DNA from blood samples to detect minimal residual disease and treatment response in real time with ultra-sensitive detection thresholds. Generates recurring revenue through subscription-based monitoring services for oncology practices, enabling early intervention and reducing patient mortality while commanding $500-$2,000 per quarterly monitoring cycle.
Precision Oncology Genomics Platform Development Click to view more details →
Tumor Mutational Burden and Mutational Signature Analysis
Calculating TMB from somatic variant calls and deconvolving mutational signatures using SigProfiler for understanding DNA damage mechanisms in tumors.
Cancer Genomics Click to view more details →
Fusion Gene Detection from Cancer RNA-Seq
Identifying oncogenic gene fusions using STAR-Fusion, Arriba, and FusionCatcher from tumor RNA sequencing for targetable driver discovery.
Cancer Genomics Click to view more details →
Immunotherapy Biomarker Prediction Engine for Treatment Selection
A machine learning platform that integrates genomic data, tumor microenvironment profiling, and clinical outcomes to predict which patients will respond to checkpoint inhibitors and other immunotherapies. Delivers precise patient stratification that increases immunotherapy response rates by 30-40%, enabling pharmaceutical companies and clinical oncology centers to optimize treatment protocols and reduce healthcare costs by billions annually.
Precision Oncology Genomics Platform Development Click to view more details →
Clonal Evolution and Tumor Heterogeneity Analysis
Reconstructing tumor phylogenies and quantifying clonal heterogeneity using PyClone and MOBSTER from multi-region tumor sequencing data.
Cancer Genomics Click to view more details →
Multi-Cancer Early Detection Genomic Screening Platform
A comprehensive liquid biopsy platform that detects circulating tumor DNA signatures for 50+ cancer types from a single blood draw, enabling asymptomatic screening in healthy populations. Positions the platform as a preventative healthcare tool with potential DTC and B2B2C revenue models, capturing market opportunity valued at $15-$25 billion by 2030 for early cancer detection screening.
Precision Oncology Genomics Platform Development Click to view more details →